Source: FinanzNachrichten

REVA: REVA Medical, LLC: REVA MEDICAL ANNOUNCES INITIATION OF ENROLLMENT IN THE MOTIV IDE CLINCIAL TRIAL

SAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, today announced that enrollment in the MOTIV pivotal trial ha...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Jeff Anderson's photo - President of REVA

President

Jeff Anderson

CEO Approval Rating

84/100

Read more